| Product NDC: | 27808-001 |
| Proprietary Name: | Cetirizine Hydrochloride |
| Non Proprietary Name: | Cetirizine Hydrochloride |
| Active Ingredient(s): | 5 mg/5mL & nbsp; Cetirizine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 27808-001 |
| Labeler Name: | Tris Pharma Inc |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA090572 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121121 |
| Package NDC: | 27808-001-01 |
| Package Description: | 30 mL in 1 BOTTLE, GLASS (27808-001-01) |
| NDC Code | 27808-001-01 |
| Proprietary Name | Cetirizine Hydrochloride |
| Package Description | 30 mL in 1 BOTTLE, GLASS (27808-001-01) |
| Product NDC | 27808-001 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Cetirizine Hydrochloride |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20121121 |
| Marketing Category Name | ANDA |
| Labeler Name | Tris Pharma Inc |
| Substance Name | CETIRIZINE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |